BD: Xcell Therapeutics teams up with BD to boost sales, secures exclusive distribution in Korea
After falling short of 2 billion won ($1.4 million) in annual revenue last year, Xcell Therapeutics is turning to Becton, Dickinson and Company's (BD) lab equipment to reboot its commercial strategy.The Kosdaq-listed cell culture media maker said Thursday that it has signed a distribution deal with
Read full article »
BD is a New Jersey-based manufacturer and supplier of medical devices, laboratory instruments and reagents for hospitals and clinical labs.
Read more